GLP-1RA Dispensing in Youth With Type 2 Diabetes: 2020 to 2023
GLP-1RA dispensing increased in youth with T2D, but the type of GLP-1RA differed by insurance type. Comparative effectiveness studies and research identifying barriers to GLP-1RA use are needed to ensure optimal treatment of youth with T2D.
Authors
- Sandra L. Amaral (ORCID: https://orcid.org/0000-0001-9473-3739)
- Mary Ellen Vajravelu (ORCID: https://orcid.org/0000-0002-5839-7923)
- Sean Hennessy
- Patricia Y. Chu (ORCID: https://orcid.org/0000-0002-4633-1716)
- Andrea Kelly
- Jing Huang
Institutions
- Children's Hospital of Philadelphia (US)
- University of Pittsburgh (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- PEDIATRICS
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1542/peds.2025-071971
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00